Yidi Suaner Na (依地酸二钠)依地酸二钠
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
No product-level labeled indications/safety are joined for this record.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 武汉久安药业有限公司Chinese legal name: 武汉久安药业有限公司
主要成分Active Ingredients
- 依地酸二钠Yidi Suaner Na
- 稀硫酸Xiliu Suan
- 枸橼酸钠Juyuan Suanna
- 注射用水Water for Injection (注射用水)
药物知识说明
依地酸二钠是一种在国家药监局注册认定的药品。该药品含有依地酸二钠、枸橼酸钠、注射用水-4ef6f8fd等成分。
该药品关联的活性成分包括:依地酸二钠Yidi Suaner Na、枸橼酸钠Juyuan Suanna、注射用水。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为:武汉久安药业有限公司Chinese legal name: 武汉久安药业有限公司。
您可以探索含有相同成分的其他药品:依地酸二钠-e06955e8成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 依地酸二钠) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 依地酸二钠Yidi Suaner Na, 枸橼酸钠Juyuan Suanna.
Manufacturers recorded for this product: 武汉久安药业有限公司Chinese legal name: 武汉久安药业有限公司.
Explore other medicines containing the same ingredient: 依地酸二钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 依地酸二钠Recorded Chinese name: 依地酸二钠
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
注册信息NMPA approval number
- 批准文号NMPA approval number: GYZH42020899
- 哈希页恢复注册号(来源 Phase 31.2B / name_index_only)Registration recovered for hash slug (Phase 31.2B / name_index_only)
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: medicine_name_index (INDEX_ONLY)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.